Pfizer (PFE) Completes Acquisition of AstraZeneca's (AZN) Small Molecule Anti-Infective Business
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) today announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
